We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Biopharmaceutical firm XBiotech has partnered with non-profit BioBridge Global to develop a Covid-19 therapy using natural antibodies from convalescent plasma of recovered patients.